To analyze the cost-effectiveness of needle core biopsy (NCB) in a breast cancer screening program.
A computer model was used to compare two hypothetical groups of women: those who undergo annual mammographic screening and those observed without screening.
All clinically significant outcomes for each group were included in the model, which reflected the state of a woman's health each year beginning at age 40 years and ending at age 85 years.
The marginal cost per year of life saved by screening was reduced a maximum of 23% (from $20,770 to $15,934) with use of NCB instead of surgical biopsy.
The cost of NCB had less effect on cost-effectiveness than the number of women who underwent NCB.
Mots-clés Pascal : Glande mammaire pathologie, Economie santé, Glande mammaire, Dépistage, Exploration, Homme, Radiodiagnostic, Radiographie, Biopsie, Mammographie, Analyse coût
Mots-clés Pascal anglais : Mammary gland diseases, Health economy, Mammary gland, Medical screening, Exploration, Human, Radiodiagnosis, Radiography, Biopsy, Mammography, Cost analysis
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 94-0198770
Code Inist : 002B24O11. Création : 199406.